UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 安定狭心症のマネージメントにおけるβ遮断剤 beta blockers in the management of stable angina pectoris
2. 重度慢性閉塞性肺疾患（COPD）および心血管疾患患者のマネージメント management of the patient with severe copd and cardiovascular disease
3. 心血管系剤によって誘発された肺疾患 pulmonary disease induced by cardiovascular drugs
4. 急性冠症候群：β遮断剤の役割 acute myocardial infarction role of beta blocker therapy
5. 高血圧緊急症の治療に用いる薬物 drugs used for the treatment of hypertensive emergencies

English Journal

Danelich IM, Reed BN, Sueta CA.SourceDepartment of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN55905 USA. danelich.ilya@mayo.edu.
Current cardiology reviews.Curr Cardiol Rev.2013 Nov 17. [Epub ahead of print]
Heart failure (HF) is an epidemic associated with significant morbidity and mortality, affecting over 5 million people in the United States and 1-2% of the population worldwide. Observational studies have suggested that a healthy lifestyle can reduce HF risk. Although no clinical trials have targete
PMID 24251457

Cardiac risk assessment, morbidity prediction, and outcome in the vascular intensive care unit.

Dover M, Tawfick W, Hynes N, Sultan S.Source1Western Vascular Institute, Department of Vascular and Endovascular Surgery, Galway University Hospital, Newcastle Road, Galway, Ireland.
Vascular and endovascular surgery.Vasc Endovascular Surg.2013 Nov;47(8):585-94. doi: 10.1177/1538574413502551. Epub 2013 Sep 17.
Objectives: The aim of this study is to examine the predictive value of the Lee revised cardiac risk index (RCRI) for a standard vascular intensive care unit (ICU) population as well as assessing the utility of transthoracic echocardiography and the impact of prior coronary artery disease (CAD) and
PMID 24048256

Alpha-1-Adrenergic Receptors in Heart Failure: The Adaptive Arm of the Cardiac Response to Chronic Catecholamine Stimulation.

Jensen BC, Oʼconnell TD, Simpson PC.SourceaDivision of Cardiology and McAllister Heart Institute, University of North Carolina, Chapel Hill, NC bDepartment of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN cCardiology Division, VA Medical Center, and Cardiovascular Research Institute and Department of Medicine, University of California, San Francisco, CA.
Journal of cardiovascular pharmacology.J Cardiovasc Pharmacol.2013 Oct 18. [Epub ahead of print]
Alpha-1-adrenergic receptors are G-protein coupled receptors (GPCRs) activated by catecholamines. The alpha-1A and alpha-1B subtypes are expressed in mouse and human myocardium, whereas the alpha-1D protein is found only in coronary arteries. There are far fewer alpha-1-ARs than beta-ARs in the non-
PMID 24145181

Effect of the Sarcolemmal K_<ATP> Channel Blocker HMR1098 on Arrhythmias Induced by Programmed Electrical Stimulation in Canine Old Myocardial Infarction Model : Comparison With Glibenclamide

Zhu Bing-Mei,Miyamoto Shigeki,Nagasawa Yoshinobu [他],WAJIMA Teruaki,HASHIMOTO Keitaro
Journal of pharmacological sciences 93(1), 106-113, 2003-09-01
… A new sulfonylthiourea, HMR1098 (1-{5-[2-(5-chloro-o-anisamido)ethyl]-2-methoxyphenylsulfonyl}-3-methylthiourea, sodium salt), was demonstrated to be a cardioselective KATP-channel antagonist and to suppress arrhythmias during acute ischemia. …
NAID 130000073961

Pharmacological Characterization of Vasorelaxant Effects of BMS-180448, a Novel Cardioselective ATP-Sensitive Potassium Channel Opener, in Rat Aorta

Park Yang-Su,Yoo Sung-Eun,Shin Hwa-Sup [他],JIN Yong-Ri,YUN Yeo-Pyo
Journal of pharmacological sciences 92(3), 218-227, 2003-07-01
… This study was designed to characterize vasorelaxant effects of BMS-180448 ((3S-trans)-N-(4-chlorophenyl)-N'-cyano-N-(6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl)), a prototype cardioselective ATP-sensitive potassium channel opener, in rat aorta. …
NAID 130000073649